226 related articles for article (PubMed ID: 18514475)
1. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy.
Hansson J; Graf W; Påhlman L; Nygren P; Mahteme H
Eur J Surg Oncol; 2009 Feb; 35(2):202-8. PubMed ID: 18514475
[TBL] [Abstract][Full Text] [Related]
2. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
4. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.
Jacquet P; Stephens AD; Averbach AM; Chang D; Ettinghausen SE; Dalton RR; Steves MA; Sugarbaker PH
Cancer; 1996 Jun; 77(12):2622-9. PubMed ID: 8640714
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing early postoperative recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Arakelian E; Gunningberg L; Larsson J; Norlén K; Mahteme H
Eur J Surg Oncol; 2011 Oct; 37(10):897-903. PubMed ID: 21783337
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis.
Spiliotis J; Rogdakis A; Vaxevanidou A; Datsis A; Zacharis G; Christopoulou A
J BUON; 2009; 14(2):259-64. PubMed ID: 19650176
[TBL] [Abstract][Full Text] [Related]
9. Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei.
Andréasson H; Graf W; Nygren P; Glimelius B; Mahteme H
Eur J Surg Oncol; 2012 Oct; 38(10):962-8. PubMed ID: 22809859
[TBL] [Abstract][Full Text] [Related]
10. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.
Klaver YL; Chua TC; de Hingh IH; Morris DL
J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124
[TBL] [Abstract][Full Text] [Related]
13. Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kusamura S; Baratti D; Antonucci A; Younan R; Laterza B; Oliva GD; Gavazzi C; Deraco M
Ann Surg Oncol; 2007 Dec; 14(12):3443-52. PubMed ID: 17909918
[TBL] [Abstract][Full Text] [Related]
14. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
Yan TD; Bijelic L; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
[TBL] [Abstract][Full Text] [Related]
15. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
[TBL] [Abstract][Full Text] [Related]
16. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
17. Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment.
Chua TC; Saxena A; Schellekens JF; Liauw W; Yan TD; Fransi S; Zhao J; Morris DL
Ann Surg; 2010 Jan; 251(1):101-6. PubMed ID: 19838105
[TBL] [Abstract][Full Text] [Related]
18. Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures.
Saxena A; Yan TD; Morris DL
Eur J Surg Oncol; 2010 Mar; 36(3):309-14. PubMed ID: 19615849
[TBL] [Abstract][Full Text] [Related]
19. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?
Goéré D; Malka D; Tzanis D; Gava V; Boige V; Eveno C; Maggiori L; Dumont F; Ducreux M; Elias D
Ann Surg; 2013 Jun; 257(6):1065-71. PubMed ID: 23299520
[TBL] [Abstract][Full Text] [Related]
20. Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy.
Hadi R; Saunders V; Utkina O; Clingan P; Kam P; Links M; Morris DL
ANZ J Surg; 2006 Mar; 76(3):156-61. PubMed ID: 16626358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]